Biotech

All Articles

Sanofi flunks MS research, giving an additional strike to Denali treaty

.Sanofi has ceased a phase 2 ordeal of Denali Therapeutics-partnered oditrasertib in numerous sclero...

Turnstone lays off 60%, shakes up C-suite to stretch out cash money

.Turnstone Biologics is decreasing its headcount through 60% and also agitating its C-suite in order...

Gilead quits on $15M MASH wager after reviewing preclinical data

.In a year that has found a permission and a raft of readouts for metabolic dysfunction-associated s...

Texas biotech axes cancer treaty, pins wishes on obesity

.Alaunos Rehabs is axing an arrangement along with Precigen, surrendering licensing civil liberties ...

Capricor shares much more data for DMD treatment after triggering BLA

.Capricor Therapies is actually taking a triumph tour for their stage 2 Duchenne muscular dystrophy ...

FDA places Kezar lupus trial in grip observing 4 person deaths

.The FDA has placed Kezar Life Sciences' lupus trial on hold after the biotech hailed 4 deaths durin...

Phase 3 Historian Stone test attacks SMA target, sending out stock up 200%

.A stage 3 trial of Intellectual Stone's spine muscle degeneration (SMA) applicant has reached its k...

CAMP 4 is most up-to-date to eye IPO, while Upstream describe $182M plan

.RNA biotech CAMP4 Rehabs has defined plans for a $67 thousand IPO, with inflammation-focused Upstre...

Galecto buys leukemia medication, goes down bone tissue cancer possession in pivot

.A year after the failing of an idiopathic pulmonary fibrosis prospect delivered Galecto on a seek r...

Judo tosses down $100M to knock senseless renal disease

.Taking the floor covering is actually Judo Biography, an up-and-coming biotech equipped along with ...